Navigation Links
GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab)
Date:5/16/2008

ading dose) or TYKERB alone (1500 mg QD). Patients were heavily pre-treated and had received a median of six prior anti-cancer regimens. Patients had received a median of three prior lines of trastuzumab (1).

The primary endpoint of the study was progression-free survival, and secondary endpoints included clinical benefit rate (CR+PR+SD greater than or equal to 24 weeks), response rate, and overall survival. If patients progressed on the TYKERB monotherapy arm after four weeks of therapy, they could cross over to receive the combination of TYKERB + trastuzumab. Adverse events were similar in both arms, with Grade 1/2 diarrhea higher in the TYKERB + trastuzumab arm (53 percent vs. 41 percent; p=0.03). Two patients in the combination arm and one patient in the TYKERB monotherapy arm experienced symptomatic decreases in left ventricle ejection fracture (LVEF); one patient in the TYKERB + trastuzumab arm died due to a pulmonary thromboembolism with progressive malignant pleural effusions; two patients with LVEF decrease later recovered. Isolated cases of asymptomatic transient decreases in LVEF were noted in both treatment arms (1).

Additional Breast Cancer Data for Investigational Uses of TYKERB to be Presented at ASCO

GSK Oncology will also be presenting for the first time results of two studies evaluating TYKERB in combination with other targeted therapies, including TYKERB + pazopanib, GSK's investigational, oral, multikinase angiogenesis inhibitor, and TYKERB + bevacizumab. Final results from a trial evaluating TYKERB monotherapy in inflammatory breast cancer (IBC) will also be presented on-site. For more information on date and time of presentation, visit http://www.asco.org.

"The breadth of data to be presented at ASCO this year is truly remarkable and signifies the commitment of GSK Oncology to being at the forefront of cancer research," said Paolo Paoletti, M.D., Senior Vice President o
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
2. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
3. BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting
4. IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
5. Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial
6. Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization
7. Kosan Announces Data Presentations at ASCO 2008 Annual Meeting
8. XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
9. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
10. Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
11. Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... HILDEN , Deutschland, und ... , ... ermöglicht QIAGEN die Entwicklung von ... Genpanels, für Blutkrebs  Neuer Test ... Patienten mit Knochenmarkserkrankungen (myelodysplastischen Syndromen) einen günstigen ...
(Date:7/24/2014)...  Mettler-Toledo International Inc. (NYSE: MTD ) ... are the highlights: , Sales in local ... the prior year. Reported sales increased 5% which included ... per diluted share as reported (EPS) were $2.49, compared ... EPS was $2.57, an increase of 9% over the ...
(Date:7/24/2014)... -- IGI Laboratories, Inc. (NYSE MKT: IG), a ... company, today announced it has accepted  Damian Finio,s ... has accepted a senior level finance position at a ... of his new position, Mr. Finio will be unable ... Laboratories, Inc.  The effective date of his resignation will ...
Breaking Medicine Technology:QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 14IGI Laboratories, Inc. Announces Change To Its Board Of Directors 2
... 2012   OncoSec Medical Incorporated (OTCBB:ONCS), which ... ElectroOncology therapies to treat solid tumor cancers, today ... biomarker strategy with the goal of identifying and ... the selection of patients potentially responsive to the ...
... 8, 2012  S1 Pharmaceuticals, Inc., a developer of therapeutics for ... addition and Scientific Advisory Board appointment to strengthen and expand ... Pyke, MD, PhD, a member of the S1 Advisory Board ... Chief Medical Officer. , Molly A. Katz, MD was ...
Cached Medicine Technology:OncoSec to Evaluate Potential Predictive or Prognostic Biomarkers for Treatment of Solid Tumor Cancers Using OMS ElectroImmunotherapy 2OncoSec to Evaluate Potential Predictive or Prognostic Biomarkers for Treatment of Solid Tumor Cancers Using OMS ElectroImmunotherapy 3S1 Pharmaceuticals Announces New Executive Management and Scientific Advisory Board Appointments 2S1 Pharmaceuticals Announces New Executive Management and Scientific Advisory Board Appointments 3
(Date:7/26/2014)... 26, 2014 As morcellator lawsuits ( ... U.S. courts, Bernstein Liebhard LLP notes that more doctors ... ban uterine morcellation. According to a report from The ... four from California who was diagnosed with a rare ... 10 days after undergoing a laparoscopic hysterectomy where a ...
(Date:7/26/2014)... OH (PRWEB) July 26, 2014 Another DePuy ... DePuy Orthopedics, Inc., has been filed by Wright & Schulte ... filed on behalf of an Erie County, Ohio man ... his left hip and groin since receiving his Pinnacle Hip ... Ohio man will be forced to undergo a complex and ...
(Date:7/26/2014)... According to the "Get Rid Tattoo Naturally" ... comprehensive guide that provides readers with safe and natural ... also teaches them how to fade dark colored tattoos, ... own home for drastic results. , Vkool reveals ... includes step-by-step tutorials and product recommendations for treating different ...
(Date:7/25/2014)... PersonalInjurySolicitorsIreland, a legal claims company ... who have suffered from a variety of injuries, ... new company, and a website, http://www.PersonalInjurySolicitorsIreland.com . ... explained, http://www.personalinjurysolicitorsireland.com/personal-injury-claims , the law firm specialises ... company is always on the client, and everyone ...
(Date:7/25/2014)... July 26, 2014 According to ... Market by Product (vibration monitoring, thermography, ultrasound emission, ... analysis), Component, Application and Geography - Global Forecast ... machine health monitoring market is expected to reach ... to 2020. , Browse 117 market data Tables ...
Breaking Medicine News(10 mins):Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes New Calls for Ban on Uterine Mocellation In Light of Cancer Risk 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes New Calls for Ban on Uterine Mocellation In Light of Cancer Risk 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes New Calls for Ban on Uterine Mocellation In Light of Cancer Risk 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 5Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 2Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 3Health News:PersonalInjurySolicitorsIreland.com Announces the Launch of their New Company and Website 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 4
... 2010) Results from four innovative studies help answer ... various hematologic malignancies. Research will be presented today at ... Hematology reveals that there is no increase in overall ... that the utilization of a double cord blood stem ...
... is more common in women than men, irrespective of occupation ... their male counterparts. Women also perceive everyday life to be ... Sweden. "There is an ongoing debate amongst researchers as ... are so common, and why this seems to be more ...
... team of researchers led by the University of East Anglia ... the early detection and diagnosis of inflammatory bowel disease. ... which allows clinicians to view the bacteria that are thought ... and ulcerative colitis. "Bacteria within the wall of the ...
... By Julia VanTine HealthDay Reporter , MONDAY, ... punishments at school and in the court system than ... Yale University study suggests. "Our analysis found ... greater risk of being punished by school and criminal-justice ...
... , SATURDAY, Dec. 4 (HealthDay News) -- Advances ... for increased survival, according to two studies scheduled to ... Saturday in Orlando, Fla. Results from one study ... can improve survival, while another group of researchers are ...
... time, researchers have established a clear link between ... gay, bisexual and transgender (LGBT) children and significantly ... The study shows that specific parental and caregiver ... when they are mistreated because of their LGBT ...
Cached Medicine News:Health News:Studies highlight role of stem cell transplant procedures for blood cancer treatment 2Health News:Studies highlight role of stem cell transplant procedures for blood cancer treatment 3Health News:Studies highlight role of stem cell transplant procedures for blood cancer treatment 4Health News:Studies highlight role of stem cell transplant procedures for blood cancer treatment 5Health News:Studies highlight role of stem cell transplant procedures for blood cancer treatment 6Health News:Studies highlight role of stem cell transplant procedures for blood cancer treatment 7Health News:Studies highlight role of stem cell transplant procedures for blood cancer treatment 8Health News:Studies highlight role of stem cell transplant procedures for blood cancer treatment 9Health News:Studies highlight role of stem cell transplant procedures for blood cancer treatment 10Health News:Stress and neck pain more common in women than men 2Health News:Gay Teens Punished More Harshly Than Straight Peers: Analysis 2Health News:Gay Teens Punished More Harshly Than Straight Peers: Analysis 3Health News:Blood Cancer Advances May Improve Survival 2Health News:Blood Cancer Advances May Improve Survival 3Health News:Study finds family acceptance of LGBT youth protects against depression, substance abuse, suicide 2Health News:Study finds family acceptance of LGBT youth protects against depression, substance abuse, suicide 3Health News:Study finds family acceptance of LGBT youth protects against depression, substance abuse, suicide 4
... Dissectron ultrasonic aspirator, ... ultrasonic surgical aspirator for ... of tissue available only ... Gathers in a very ...
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 10.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Temporary mini-type 1/1 (mm), opening width 5.0 mm and length 6 mm....
Medicine Products: